FREAMINE III 3% W/ ELECTROLYTES
LOE Approachingamino acids; magnesium acetate; phosphoric acid; potassium chloride; sodium acetate; sodium chloride
NDAINJECTIONINJECTABLEPriority Review
Approved
Sep 1971
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FREAMINE III 3% w/ Electrolytes is a parenteral nutrition formulation combining amino acids with essential electrolytes (magnesium, potassium, sodium, phosphate) delivered by intravenous injection. It provides nutritional support and metabolic balance for patients unable to maintain adequate oral intake. This is a foundational critical care and hospital nutrition product used across intensive care, perioperative, and chronic illness settings.
LOE Approaching
This mature, generic-category product faces moderate competitive pressure (30%) and is approaching loss of exclusivity; commercial teams are likely focused on hospital formulary management and cost defense rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on FREAMINE III offers career stability in hospital-based pharmaceutical operations and supply chain management, but limited upside for clinical innovation or commercial growth. Professionals on this team typically focus on formulary relationships, manufacturing efficiency, and cost management rather than product expansion or breakthrough science.
Hospital Account Manager
Worked on FREAMINE III 3% W/ ELECTROLYTES at B. Braun? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.